Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?
about
Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery diseaseThe urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialDiagnosis and management of goutUric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney DiseaseSLC2A9 is a high-capacity urate transporter in humansMetabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changesAssociation of serum uric acid with 2-hour postload glucose in Chinese with impaired fasting plasma glucose and/or HbA1cTriuret as a potential hypokalemic agent: Structure characterization of triuret and triuret-alkali metal adducts by mass spectrometric techniquesSerum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.Uric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant.Hyperuricemia and incident heart failure.Serum Uric Acid level in the severity of Congestive Heart Failure (CHF).Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studiesUric acid as one of the important factors in multifactorial disorders--facts and controversies.Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population.Hyperuricemia and the risk for subclinical coronary atherosclerosis--data from a prospective observational cohort study.Serum uric acid in patients with acute ST-elevation myocardial infarctionHyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study.Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010.The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention TrialReduced glomerular function and prevalence of gout: NHANES 2009-10Emerging therapies in the long-term management of hyperuricaemia and gout.Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan.Determinants of vascular function in patients with chronic gout.The association between shift work and hyperuricemia in steelmaking male workersHyperuricemia in obese children and adolescents: the relationship with metabolic syndromeHyperuricemia and coronary heart disease: a systematic review and meta-analysis.Serum Urate and Incident Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational studyRelationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional StudyHyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction.Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studiesThe Establishment and Characteristics of Rat Model of Atherosclerosis Induced by HyperuricemiaAcute myocardial infarction and acute coronary syndrome: then and now (1950-2005).Monosodium urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein secretion from human primary macrophages.Association of Serum Uric Acid with Cardiovascular Disease in Taiwanese Patients with Primary Hypertension.Uric acid and the development of metabolic syndrome in women and menUric acid: an old actor for a new role.Serum urate levels and consumption of common beverages and alcohol among Chinese in Singapore.
P2860
Q21091170-7770FE5D-A1ED-4E9D-80A6-6C79CF808B23Q21195361-D4442364-0DE7-431D-8411-8503A7131450Q24546235-FE8B8005-10DC-42CD-A9DC-7B1C54D572EAQ24678615-F8FB0EFB-253E-41E3-8B69-A421DE96D954Q26739475-AA1A6294-B207-4E49-BB93-16CB828FD5BAQ28473781-2E46C894-9AF1-43CD-ABAA-A84CE338BC73Q28474849-143CBACD-0BC5-4020-9C2C-67A1B0D8E526Q28534505-98A62D96-C232-4D10-B380-51685667216AQ28661791-2E43DC9C-1C10-4EC0-9EBF-131093D73CD7Q31129762-D81F8DD8-6E1E-4EF5-9B23-66E0F39B0D2CQ33358818-B4B95DE0-52DE-48C5-A663-D231C9D73404Q33572047-6A7C09D1-7100-4227-B7B5-7AEF53132496Q33690310-C7017425-911A-4C13-92A0-1686FC3D4B7EQ33770852-62F7ED5E-46AD-4A57-8DD3-91DB57F0DAE5Q33773142-26C4B087-28D1-4F92-8281-9312D656B5E7Q33860337-C7D0CBB7-8305-4845-B939-5A80675D7BBBQ33875877-E6B143B9-2EFC-49CD-BBAC-EBED86F2FE6EQ34032147-D617E906-2CE6-4EB0-9329-47956D5B7441Q34215960-5CA4D573-CD45-40A5-9BCF-7399D24F96ECQ34297252-4F7985D2-860E-4B32-AAF2-37964FD78C02Q34310754-9BF1518D-04E7-4097-9F33-2D319D4A512DQ34499903-AB2B6C76-820A-4B1A-922E-A83939CEEDFCQ34578135-CF544159-296D-453A-9C48-6E08346E0E6BQ34700314-CBDF676A-8A77-4539-A136-7ECD53048CB3Q34788956-C2847BC9-3867-4CC6-A029-48C0AF7BF84CQ34789441-27CF684F-8EE8-4A30-97CF-019E79894FA9Q34979498-AB5E339C-6CE0-4FE5-A193-03154F1FDFD0Q35166411-5976857F-FB13-48E8-B4C7-F9727FB14455Q35779443-0B063584-6AD1-4CE8-A8AA-65143FE403ADQ35964755-8C3FE1F9-F682-43CA-8A72-9143AD51648AQ36078408-E8DB7B42-198F-4D5D-8FAF-7BF75E05ECDAQ36084907-4B11645D-9321-4AF5-B9FD-B71130F56F0DQ36177428-7ADF7401-4FFF-45A8-B8C3-8DEAB6DAD520Q36405350-8D103B7A-CA62-4678-BE1B-93007A9021A5Q36645635-1BE031D7-F5BA-4C01-A850-35604952E829Q36666383-04F1EF60-638B-4F0E-85B5-94D2BAEC2995Q36721576-B481D864-8A70-467F-9CA0-2976B9EEA4B6Q36794999-DAE4F985-DCA3-4CEB-B8A6-DC921355C558Q36841547-509F3483-4239-4EC1-B97E-1D10144C1B4DQ37010264-83D08909-5349-4864-9E41-FAB889C28D49
P2860
Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Serum uric acid and cardiovasc ...... s, and where do they leave us?
@ast
Serum uric acid and cardiovasc ...... s, and where do they leave us?
@en
type
label
Serum uric acid and cardiovasc ...... s, and where do they leave us?
@ast
Serum uric acid and cardiovasc ...... s, and where do they leave us?
@en
prefLabel
Serum uric acid and cardiovasc ...... s, and where do they leave us?
@ast
Serum uric acid and cardiovasc ...... s, and where do they leave us?
@en
P2093
P1476
Serum uric acid and cardiovasc ...... s, and where do they leave us?
@en
P2093
Eswar Krishnan
H Ralph Schumacher
Joshua F Baker
P304
P356
10.1016/J.AMJMED.2005.03.043
P407
P577
2005-08-01T00:00:00Z